DECOY20 Study in Patients with Advanced Solid Tumors

This study tests a new cancer treatment called Decoy20 for people with advanced tumors. Decoy20 is a type of immunotherapy, which means it helps the body’s immune system fight cancer. The study is in Phase 1, meaning researchers are checking if it's safe and how well it works. It has three parts: Part 1 tests a single dose, Part 2 tests weekly doses, and Part 3 tests longer use.

• Participants will need regular visits for up to a year to receive the treatment.
• People with certain types of cancer like liver, lung, or pancreatic cancer can join.
• There are risks like side effects, and participants must meet specific health conditions to join.

Before joining, participants must be adults with a confirmed advanced cancer diagnosis and should have tried other treatments first. Pregnant women or those with serious infections or other health issues cannot participate. The study will monitor health and safety closely, especially after each treatment dose. Always discuss with your doctor to see if this study is right for you.